Correlation Between Pfizer and 025816CW7
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and AXP 405 03 MAY 29, you can compare the effects of market volatilities on Pfizer and 025816CW7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 025816CW7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 025816CW7.
Diversification Opportunities for Pfizer and 025816CW7
Good diversification
The 3 months correlation between Pfizer and 025816CW7 is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and AXP 405 03 MAY 29 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AXP 405 03 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 025816CW7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AXP 405 03 has no effect on the direction of Pfizer i.e., Pfizer and 025816CW7 go up and down completely randomly.
Pair Corralation between Pfizer and 025816CW7
Considering the 90-day investment horizon Pfizer Inc is expected to generate 2.9 times more return on investment than 025816CW7. However, Pfizer is 2.9 times more volatile than AXP 405 03 MAY 29. It trades about 0.01 of its potential returns per unit of risk. AXP 405 03 MAY 29 is currently generating about -0.01 per unit of risk. If you would invest 2,593 in Pfizer Inc on November 3, 2024 and sell it today you would earn a total of 59.00 from holding Pfizer Inc or generate 2.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. AXP 405 03 MAY 29
Performance |
| Timeline |
| Pfizer Inc |
| AXP 405 03 |
Pfizer and 025816CW7 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and 025816CW7
The main advantage of trading using opposite Pfizer and 025816CW7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 025816CW7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 025816CW7 will offset losses from the drop in 025816CW7's long position.| Pfizer vs. Agilent Technologies | Pfizer vs. Equillium | Pfizer vs. 23Andme Holding Co | Pfizer vs. DiaMedica Therapeutics |
| 025816CW7 vs. AEP TEX INC | 025816CW7 vs. US BANK NATIONAL | 025816CW7 vs. Reliance Global Group | 025816CW7 vs. Bayerische Motoren Werke |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |